Intersect ENT has agreed to acquire Fiagon AG Medical Technologies – Click here to learn more

Investor Relations

News

Date Title and Summary Additional Formats
Toggle Summary Intersect ENT to Present at the 2020 Bank of America Merrill Lynch Global Healthcare Conference
MENLO PARK, Calif. --(BUSINESS WIRE)--May 7, 2020-- Intersect ENT, Inc. (Nasdaq: XENT ), today announced that management will participate in a virtual fireside chat at the Bank of America Merrill Lynch Global Healthcare Conference . The fireside chat will take place on Thursday, May 14, 2020 at
View HTML
Toggle Summary Intersect ENT to Report First Quarter 2020 Financial Results
MENLO PARK, Calif. --(BUSINESS WIRE)--Apr. 28, 2020-- Intersect ENT, Inc. (Nasdaq: XENT), a company transforming care for patients with ear, nose and throat (“ENT”) conditions, today announced that it will release first quarter 2020 financial results on May 11, 2020 .
View HTML
Toggle Summary Intersect ENT Announces Preliminary Revenue for First Quarter 2020 and Provides Business Update in Response to COVID-19 Pandemic
- Preliminary Unaudited First Quarter 2020 Revenue Expected to be $19.5 to $19.8 Million - - Company Withdraws Full Year 2020 Guidance - MENLO PARK, Calif. --(BUSINESS WIRE)--Apr. 13, 2020-- Intersect ENT, Inc. (Nasdaq: XENT), a company transforming care for patients with ear, nose and throat
View HTML
Toggle Summary Intersect ENT Reports Fourth Quarter and Full Year 2019 Results
MENLO PARK, Calif. --(BUSINESS WIRE)--Feb. 24, 2020-- Intersect ENT, Inc. (NASDAQ:XENT), a company transforming care for patients with ear, nose and throat (“ENT”) conditions, today reported financial results for the fourth quarter and full year ended December 31, 2019 .
View HTML
Toggle Summary Intersect ENT to Report Fourth Quarter and Year 2019 Financial Results
MENLO PARK, Calif. --(BUSINESS WIRE)--Feb. 5, 2020-- Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced that it will release fourth quarter and year 2019 financial results on February 24, 2020 .
View HTML
Toggle Summary Intersect ENT to Present at the 9th Annual SVB Leerink Global Healthcare Conference
MENLO PARK, Calif. --(BUSINESS WIRE)--Feb. 5, 2020-- Intersect ENT, Inc. (Nasdaq: XENT), today announced that management will participate in the 9th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 26, 2020 at the Lotte New York Palace in New York City , and will present in a
View HTML
Toggle Summary Intersect ENT Reports Preliminary Full Year 2019 Revenue
MENLO PARK, Calif. --(BUSINESS WIRE)--Jan. 13, 2020-- Intersect ENT, Inc. (NASDAQ: XENT), a company transforming care for patients with ear, nose and throat conditions, today reported preliminary unaudited revenue for the full year ended December 31, 2019 .
View HTML
Toggle Summary Intersect ENT to Present at the 38th Annual J.P. Morgan Healthcare Conference
MENLO PARK, Calif. --(BUSINESS WIRE)--Dec. 11, 2019-- Intersect ENT, Inc. (Nasdaq: XENT), today announced that management will participate in the 38 th Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2020 at the Westin St. Francis Hotel in San Francisco , and will present at 1:30
View HTML
Toggle Summary Intersect ENT Announces Appointment of New Chief Financial Officer
Toggle Summary Intersect ENT to Present at the 31st Annual Piper Jaffray Healthcare Conference
MENLO PARK, Calif. --(BUSINESS WIRE)--Nov. 19, 2019-- Intersect ENT, Inc. (NASDAQ: XENT ) today announced that management will participate in the 31 st Annual Piper Jaffray Healthcare Conference on December 4 at the Lotte New York Palace Hotel in New York City , and will present in a session at
View HTML